| ●Editorial | Fukushima M | 5-6 | Full text | |
| ●Public Debriefing Session 2014 Current status and future prospects of the network for creating medical innovations －Nurturing seeds for academic institutions in the new phase－ | 7-252 | Abstract | ||
| Organized by: Ministry of Education, Culture, Sports, Science and Technology Ministry of Health, Labour and Welfare | ||||
| Opening remarks | Tokiwa Y | 17 | ||
| Opening remarks | Futagawa K | 18 | ||
| Opening remarks by PD | Saruta T | 19 | ||
| Summation report from the program management office | Fukushima M | 23-7 | ||
| Network construction | Aoki M | 28-31 | ||
| Approach for enhancement of translational research center in Hokkaido | Sato N | 35-8 | ||
| Translational research center for Tohoku-originated development of pharmaceuticals and medical devices | Shimosegawa T | 39-42 | ||
| Advanced center for the establishment and coordination of biomedical innovation development assistance | Saito N | 43-6 | ||
| Establishment and missions of Keio University Hospital Translational and Clinical Research Center | Saya H | 47-50 | ||
| Wing of Innovation and Science for the Development of New Medical Care | Hanaoka H | 51-3 | ||
| The present and future of the network-based development sites for advanced medicine in Chubu area | Mizuno M | 54-8 | ||
| Reinforcement of academic base for development of novel drug and medical treatment | Shimizu A | 59-62 | ||
| Advanced medicine development in Osaka University as an academic research organization | Sawa Y | 63-6 | ||
| Innovative medical research and development core aiming to extend the healthy life expectancy | Nasu Y | 67-70 | ||
| Establishment of academic research organization supporting developments of innovative medicine for the next generation | Nakanishi Y | 71-4 | ||
| Cutting-edge oncology agents developmental studies in National Cancer Center | Ohtsu A | 75-8 | ||
| Construction of a hub academia for promoting the development of innovative medical devices 2015 | Minematsu K | 79-82 | ||
| Creating a center for clinical development in child health and development | Yoshikawa N | 83-6 | ||
| ARO function in National Hospital Organization and its applications | Naoe T | 87-91 | ||
| Questions and answers | 92-3 | |||
| Hokkaido Organization for Translational Research | Sugita O | 97-100 | ||
| National Cancer Center | Kaneko K | 101-3 | ||
| The University of Tokyo | Suzuki T | 104-5 | ||
| Kyoto University | Shimizu A | 106-9 | ||
| Osaka University | Murase T | 110-2 | ||
| Closing remarks | Fukushima M | 115 | ||
| Nuclear acid-based anti-RPN2 therapy | Tamura K | 119-22 | ||
| Efficacy and safety of the avian influenza A/H7N9 inactivated whole-virus vaccine produced using the embryonated egg in human (Investigator-initiated Phase I trial) | Ito S，Horibe K | 123-6 | ||
| Development of chimeric anti-GD2-antibody ch14.18 for advanced neuroblastoma | Takahashi Y | 127-9 | ||
| Phase I/II exploratory clinical trial of intracordal injection of human recombinant hepatocyte growth factor (KP-100LI) for vocal fold scar | Hirano S | 130-2 | ||
| Development of therapeutics with bone marrow mesenchymal stem cell recruiting factor for intractable skin ulcers associated with peripheral circulatory failure | Tamai K | 133-5 | ||
| Development of slow-release oxime derivative (YS-1402/ONO-1301MS) for treating advanced cardiac failure | Sawa Y，Fukushima S | 136-9 | ||
| HVJ envelope vector (HVJ-E) toward cancer gene therapy | Kaneda Y | 140-3 | ||
| Investigator (Doctor)-initiated clinical study of Okayama University-type Retinal Prosthesis (OUReP®): Biological safety, manufacturing and quality control | Matsuo T | 144-7 | ||
| Nanoparticle-mediated drug targeting for the development of innovative therapy against severe pulmonary arterial hypertension | Egashira K | 148-50 | ||
| Questions and answers | 151-3 | |||
| Patent strategy for creating disruptive innovation | Yamanaka A | 157-62 | ||
| New requirement for NDA－CDISC standardized study data | Shikano M | 163-9 | ||
| Impact of the Pharmaceutical and Medical Device Act in Japan | Miyata T | 170-6 | ||
| The lysophospholipid-producing enzymes as clinical biomarkers | Yatomi Y | 179-81 | ||
| PET Study using C-11 Methionine | Tamaki N，Hirata K | 182-4 | ||
| Development of locally controlled radical disinfection device for less-invasive and highly efficient periodontal therapy | Kanno T | 185-7 | ||
| Fetal electrocardiogram POC study: From All Japan multi-institutional and joint-research networking toward international expansion | Kimura Y | 188-91 | ||
| Multi-modality neuroimaging guided-investigation of pathophysiology and development of a diagnosis tool for psychiatric disorders | Fukuda M | 192-4 | ||
| Evaluation of efficacy and safety of the CP Stent TM for pulmonary artery stenosis | Nakamura H | 195-8 | ||
| Development of patient-specific cardiac support net for dilated cardiomyopathy | Akita T | 199-202 | ||
| Clinical trial of limbal-supported rigid type contact lens for ocular sequelae related to Stevens-Johnson syndrome and toxic epidermal necrolysis | Sotozono C | 203-5 | ||
| Development of autologous tissues for cardiovascular implantation by In Body Tissue Architecture | Nakayama Y | 206-8 | ||
| Questions and answers | 209-10 | |||
| Act on the Safety of Regenerative Medicine and Related Laws and Regulations | Iimura Y | 213-8 | ||
| Amnion-derived mesenchymal stem cells for the treatment of liver cirrhosis Amnion-derived mesenchymal stem cells for regenerative medicine and their application of the treatment of acute GVHD Fetal membrane-derived mesenchymal stem cells for the treatment of severe Crohn’s disease | Sakamoto N，Yamahara K， Ohnishi S | 221-4 | ||
| Development of the NY-ESO-1 specific TCR-engineered T-cell therapy for malignant melanoma | Kawakami Y，Funakoshi T | 225-7 | ||
| Enzyme replacement therapy by auto-transplantation of therapeutic-enzyme secreting adipocytes for familial LCAT deficiency syndrome | Yokote K，Kuroda M | 228-30 | ||
| Development of cell therapy using adipose tissue-derived stem cells for structural and functional regeneration: Development of regenerative treatment for stress urinary incontinence | Gotoh M | 231-3 | ||
| Multicenter clinical research using autologous oral mucosal epithelial cell sheets for total limbal stem-cell deficiency | Nishida K，Oie Y | 234-6 | ||
| Regenerative therapy using myoblast sheet for the treatment of adult and pediatric dilated cardiomyopathy －Bridge to transplantation/recovery－ | Sawa Y，Miyagawa S | 237-40 | ||
| Development of RNA-based gene drug for the treatment of peripheral arterial disease | Yonemitsu Y | 241-4 | ||
| Questions and answers | 245-7 | |||
| Closing remarks | Iwasaki M | 251-2 | ||
| ●Instructions for authors［Japanese］＆［English］ | 253-61 | Full text | ||